Cargando…
FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway
Gastric cancer often shows malignant growth and insensitivity to chemotherapeutic drugs due to the regulation of complex molecular mechanisms, which results in poor prognosis for patients. However, the relevant molecular mechanisms remain unclear. In this study, we reported that family with sequence...
Autores principales: | Zhou, Yunjiang, Chen, Yaxin, Shi, Yongwei, Wu, Leyin, Tan, Yingying, Li, Tao, Chen, Yigang, Xia, Jiazeng, Hu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888386/ https://www.ncbi.nlm.nih.gov/pubmed/36719368 http://dx.doi.org/10.1172/JCI158705 |
Ejemplares similares
-
FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding
por: Cheng, Kai-Chun, et al.
Publicado: (2019) -
Adipose-derived stem cell exosomes regulate Nrf2/Keap1 in diabetic nephropathy by targeting FAM129B
por: Ren, Peiyao, et al.
Publicado: (2023) -
The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017) -
Keap1/Nrf2 Signaling Pathway
por: Sykiotis, Gerasimos P.
Publicado: (2021) -
Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity
por: Guo, Jian, et al.
Publicado: (2018)